Brown & Brown faces Monday's Q1 print with short interest down 1% over the past month and borrowing costs declining. Options sentiment leans bullish, with PCR well below its 20-day average.
Short interest stands at 17.83 million shares, representing 5.2% of the free float. Shares short have declined 1% over the past month, retreating from mid-March highs near 18.5 million shares. Day-to-day activity shows modest fluctuation, with a slight 0.3% uptick in the latest session. Days to cover sits at 4.56 based on official FINRA data.
Borrow costs remain benign at 0.44%, down 13% over the past month. The decline suggests short sellers face minimal friction entering or exiting positions. Utilisation sits at 13.2%, well off the March 20 high of 18.5%. Low utilisation indicates ample shares available to borrow relative to demand.
The put-call ratio closed at 0.37 on April 23, below the 20-day mean of 0.40 and near the 52-week low of 0.22. The Z-score of -0.21 signals mildly bullish positioning. PCR spiked above 0.80 in late March before collapsing back to current levels, suggesting a shift away from hedging or bearish bets. No implied move data is available for the upcoming earnings.
BRO has reported earnings four times since late January 2026, though the snapshot does not include price reaction or EPS data. The stock is down 0.5% in the last day and 1.8% over the past week, but up 1.2% over the month. Shares closed at $67.55 on April 23.
No active ORTEX Alpha signals are currently flagged for Brown & Brown.
See the live data behind this article on ORTEX.
Open BRO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
